Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

17.27 +0.05 (+0.32%)
Streaming Delayed Price Updated: 11:52 AM EST, Nov 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
News headline image
Nvidia’s $100B Bet in OpenAI Pushes Wall Street to Fresh Records ↗
Tech did the heavy lifting as Nvidia and Apple dragged indexes over the finish line; gold hit yet another all-time high while oil sagged. The Fed chorus grew louder and more discordant. 
Via Chartmill
Topics Economy
News headline image
Johnson & Johnson Stock Weathers Trump’s Tylenol Attacks Better Than Kenvue Amid Dipping Retail Confidence — What’s Holding Losses in Check? ↗
Guggenheim’s upgrade and new data on J&J’s experimental depression drug helped steady sentiment, even as investors weighed political scrutiny and ongoing litigation risks. 
Via Stocktwits
Topics Government
News headline image
Nvidia, Kenvue, Rivian, MicroCloud Hologram And Opendoor: Why These 5 Stocks Are On Investors' Radars Today ↗
U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average edging up 0.14% to 46,381.54. 
Via Benzinga
Topics Stocks
Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullish ↗
Via Stocktwits
Topics Government
Kenvue Shares Drop Ahead Of Trump’s ‘Biggest Announcement’ On Autism: Reports Say Administration To Link Tylenol With Risk Of Disease ↗
Via Stocktwits
Topics Government
Tylenol Maker Kenvue Met With RFK Jr. In A Bid To Keep OTC Painkiller Off Autism List: Report ↗
Via Stocktwits
News headline image
What 8 Analyst Ratings Have To Say About Kenvue ↗
 
Via Benzinga
News headline image
Which S&P500 stocks are moving on Monday? ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday. 
Via Chartmill
News headline image
Curious about the most active S&P500 stocks in today's session? ↗
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Monday. Discover the stocks that are generating the highest... 
Via Chartmill
News headline image
Stocks Extend Records, Gold Soars To $3,740: What's Moving Markets Monday? ↗
Wall Street is on track for its third straight day of gains, with major large-cap indices extending records as investors remain optimistic about corporate earnings and upcoming rate cuts. 
Via Benzinga
News headline image
Kenvue Stock Is Sliding Today: What's Fueling The Sell-Off? ↗
Shares of Kenvue Inc (NASDAQ: KVUE) are down Monday in anticipation of a negative Trump administration announcement about one of its products. 
Via Benzinga
Topics Government
News headline image
Top S&P500 movers in Monday's session ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Growth Titans: Eli Lilly's Weight-Loss Surge vs. Johnson & Johnson's Diversified Might
The pharmaceutical landscape is currently a tale of two giants employing vastly different, yet highly successful, growth strategies. Eli Lilly and Company (NYSE: LLY) has placed an extraordinary bet on... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Which S&P500 stocks are gapping on Monday? ↗
Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
News headline image
What's going on in today's pre-market session: S&P500 movers ↗
Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Trump Administration To Unveil Tylenol-Autism Review, Tout This Drug As Potential Treatment: Report ↗
Trump administration to announce concerns about Tylenol use in pregnancy and potential treatment for autism, in line with President's priority. 
Via Benzinga
Topics Government
News headline image
Kenvue, J&J Retail Traders Cautious As US Health Officials Reportedly Plan To Announce Tylenol Links To Autism ↗
Tylenol is one of the most common medicines for reducing pain and fever, and a major product for Kenvue. 
Via Stocktwits
Topics Government
News headline image
Johnson & Johnson Confronts the End of its Talc Legacy with Multi-Billion Dollar Settlements
Johnson & Johnson (NYSE: JNJ) is navigating a critical juncture in its protracted legal battle over talc-based baby powder. The healthcare behemoth has announced a tentative $700 million settlement... 
Via MarketMinute
Topics Bankruptcy Death Lawsuit
News headline image
Jim Cramer's Warning On This Oil Stock: 'You Don't Want To Be In It' ↗
Jim Cramer discussed companies such as Western Union, Johnson Controls, MNTN, Nordic American Tankers, Occidental Petroleum, and Kenvue on CNBC's Mad Money Lightning Round. 
Via Benzinga
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Monday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
News headline image
Kenvue Pushes To Defend Pain Killer Tylenol Against Autism Claims Ahead Of Government Report ↗
Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and autism. 
Via Benzinga
News headline image
Which S&P500 stocks are the most active on Monday? ↗
Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session. 
Via Chartmill
News headline image
Kenvue Seen As Attractive Buy By BofA After Stock Dip Following Report On Tylenol Autism Link ↗
Evercore said that the recent selloff in shares "might be overdone" when considering the lack of a proven causal link between Tylenol's active ingredient and neurodevelopmental disorders. 
Via Stocktwits
News headline image
Market Monitor Trends and Breadth September 08 BMO - Wall Street Stumbles as Weak Jobs Report Stirs Recession Fears ↗
A softer-than-expected U.S. labor market spooked investors on Friday, dragging major indices lower despite initial optimism over potential Fed rate cuts. Gold surged to record highs as traders sought... 
Via Chartmill
Topics Economy
News headline image
Top S&P500 movers in Friday's session ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
RFK Jr. To Link Tylenol Use To Autism: Report ↗
RFK Jr. is preparing to release a report suggesting that the use of Tylenol during pregnancy may be tied to a higher risk of autism. 
Via Benzinga
News headline image
Kenvue Stock Hits One-Year Low After Report Says HHS Will Link Tylenol Use in Pregnancy to Autism Risk ↗
According to a report by The Wall Street Journal, the Department of Health and Human Services is likely to release its findings later this month. 
Via Stocktwits
Topics Economy
News headline image
Which S&P500 stocks are the most active on Friday? ↗
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest. 
Via Chartmill
News headline image
JNJ Stock Surge Signals Confidence in New Growth Path ↗
Johnson & Johnson's strategic shift to a focused pharma and medtech model is fueling growth through a powerful drug pipeline and key acquisitions. 
Via MarketBeat
Topics Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.